Global Non-24-hour Sleep-wake Disorder Treatment Market Research Report 2026(Status and Outlook)
Non-24-hour sleep-wake disorder (N24) is a circadian rhythm sleep disorder in which an individual"s biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.
The global Non-24-hour Sleep-wake Disorder Treatment market size was estimated at USD 537.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Non-24-hour Sleep-wake Disorder Treatment market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Non-24-hour Sleep-wake Disorder Treatment market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Non-24-hour Sleep-wake Disorder Treatment market.
Global Non-24-hour Sleep-wake Disorder Treatment Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Teva
Mylan
Nature?s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma
Market Segmentation (by Type)
Prescription Drugs
OTC
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Other
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Non-24-hour Sleep-wake Disorder Treatment Market
Overview of the regional outlook of the Non-24-hour Sleep-wake Disorder Treatment Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-24-hour Sleep-wake Disorder Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non-24-hour Sleep-wake Disorder Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Non-24-hour Sleep-wake Disorder Treatment market size was estimated at USD 537.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Non-24-hour Sleep-wake Disorder Treatment market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Non-24-hour Sleep-wake Disorder Treatment market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Non-24-hour Sleep-wake Disorder Treatment market.
Global Non-24-hour Sleep-wake Disorder Treatment Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Teva
Mylan
Nature?s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma
Market Segmentation (by Type)
Prescription Drugs
OTC
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Non-24-hour Sleep-wake Disorder Treatment Market
Overview of the regional outlook of the Non-24-hour Sleep-wake Disorder Treatment Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-24-hour Sleep-wake Disorder Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non-24-hour Sleep-wake Disorder Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Non-24-hour Sleep-wake Disorder Treatment
1.2 Key Market Segments
1.2.1 Non-24-hour Sleep-wake Disorder Treatment Segment by Type
1.2.2 Non-24-hour Sleep-wake Disorder Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Non-24-hour Sleep-wake Disorder Treatment Product Life Cycle
3.3 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Manufacturers (2020-2025)
3.4 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Manufacturers (2020-2025)
3.5 Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Non-24-hour Sleep-wake Disorder Treatment Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Non-24-hour Sleep-wake Disorder Treatment Market Competitive Situation and Trends
3.8.1 Non-24-hour Sleep-wake Disorder Treatment Market Concentration Rate
3.8.2 Global 5 and 10 Largest Non-24-hour Sleep-wake Disorder Treatment Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Non-24-hour Sleep-wake Disorder Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Non-24-hour Sleep-wake Disorder Treatment Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Non-24-hour Sleep-wake Disorder Treatment Market
5.7 ESG Ratings of Leading Companies
6 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Type (2020-2025)
6.3 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2020-2025)
6.4 Global Non-24-hour Sleep-wake Disorder Treatment Price by Type (2020-2025)
7 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Sales by Application (2020-2025)
7.3 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) by Application (2020-2025)
7.4 Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2020-2025)
8 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SALES BY REGION
8.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region
8.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.2.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.3 North America
8.3.1 North America Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.3.2 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.4.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.5.2 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.6.2 South America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.7.2 Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET PRODUCTION BY REGION
9.1 Global Production of Non-24-hour Sleep-wake Disorder Treatment by Region(2020-2025)
9.2 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2020-2025)
9.3 Global Non-24-hour Sleep-wake Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Non-24-hour Sleep-wake Disorder Treatment Production
9.4.1 North America Non-24-hour Sleep-wake Disorder Treatment Production Growth Rate (2020-2025)
9.4.2 North America Non-24-hour Sleep-wake Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Non-24-hour Sleep-wake Disorder Treatment Production
9.5.1 Europe Non-24-hour Sleep-wake Disorder Treatment Production Growth Rate (2020-2025)
9.5.2 Europe Non-24-hour Sleep-wake Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Non-24-hour Sleep-wake Disorder Treatment Production (2020-2025)
9.6.1 Japan Non-24-hour Sleep-wake Disorder Treatment Production Growth Rate (2020-2025)
9.6.2 Japan Non-24-hour Sleep-wake Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Non-24-hour Sleep-wake Disorder Treatment Production (2020-2025)
9.7.1 China Non-24-hour Sleep-wake Disorder Treatment Production Growth Rate (2020-2025)
9.7.2 China Non-24-hour Sleep-wake Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Teva
10.1.1 Teva Basic Information
10.1.2 Teva Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.1.4 Teva Business Overview
10.1.5 Teva SWOT Analysis
10.1.6 Teva Recent Developments
10.2 Mylan
10.2.1 Mylan Basic Information
10.2.2 Mylan Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.2.4 Mylan Business Overview
10.2.5 Mylan SWOT Analysis
10.2.6 Mylan Recent Developments
10.3 Nature?s Bounty
10.3.1 Nature?s Bounty Basic Information
10.3.2 Nature?s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.3.3 Nature?s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.3.4 Nature?s Bounty Business Overview
10.3.5 Nature?s Bounty SWOT Analysis
10.3.6 Nature?s Bounty Recent Developments
10.4 Otsuka Pharma (Pharmavite)
10.4.1 Otsuka Pharma (Pharmavite) Basic Information
10.4.2 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.4.4 Otsuka Pharma (Pharmavite) Business Overview
10.4.5 Otsuka Pharma (Pharmavite) Recent Developments
10.5 Boiron
10.5.1 Boiron Basic Information
10.5.2 Boiron Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.5.4 Boiron Business Overview
10.5.5 Boiron Recent Developments
10.6 Miers Laboratories
10.6.1 Miers Laboratories Basic Information
10.6.2 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.6.4 Miers Laboratories Business Overview
10.6.5 Miers Laboratories Recent Developments
10.7 Genexa
10.7.1 Genexa Basic Information
10.7.2 Genexa Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.7.4 Genexa Business Overview
10.7.5 Genexa Recent Developments
10.8 Homeocan
10.8.1 Homeocan Basic Information
10.8.2 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.8.4 Homeocan Business Overview
10.8.5 Homeocan Recent Developments
10.9 Clinigen Group
10.9.1 Clinigen Group Basic Information
10.9.2 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.9.4 Clinigen Group Business Overview
10.9.5 Clinigen Group Recent Developments
10.10 Vanda Pharma
10.10.1 Vanda Pharma Basic Information
10.10.2 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.10.4 Vanda Pharma Business Overview
10.10.5 Vanda Pharma Recent Developments
11 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET FORECAST BY REGION
11.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast
11.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country
11.2.3 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region
11.2.4 South America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Non-24-hour Sleep-wake Disorder Treatment by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Non-24-hour Sleep-wake Disorder Treatment by Type (2026-2035)
12.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Non-24-hour Sleep-wake Disorder Treatment by Type (2026-2035)
12.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Application (2026-2035)
12.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) Forecast by Application
12.2.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Non-24-hour Sleep-wake Disorder Treatment
1.2 Key Market Segments
1.2.1 Non-24-hour Sleep-wake Disorder Treatment Segment by Type
1.2.2 Non-24-hour Sleep-wake Disorder Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Non-24-hour Sleep-wake Disorder Treatment Product Life Cycle
3.3 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Manufacturers (2020-2025)
3.4 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Manufacturers (2020-2025)
3.5 Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Non-24-hour Sleep-wake Disorder Treatment Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Non-24-hour Sleep-wake Disorder Treatment Market Competitive Situation and Trends
3.8.1 Non-24-hour Sleep-wake Disorder Treatment Market Concentration Rate
3.8.2 Global 5 and 10 Largest Non-24-hour Sleep-wake Disorder Treatment Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Non-24-hour Sleep-wake Disorder Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Non-24-hour Sleep-wake Disorder Treatment Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Non-24-hour Sleep-wake Disorder Treatment Market
5.7 ESG Ratings of Leading Companies
6 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Type (2020-2025)
6.3 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2020-2025)
6.4 Global Non-24-hour Sleep-wake Disorder Treatment Price by Type (2020-2025)
7 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Sales by Application (2020-2025)
7.3 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) by Application (2020-2025)
7.4 Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2020-2025)
8 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SALES BY REGION
8.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region
8.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.2.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.3 North America
8.3.1 North America Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.3.2 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.4.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.5.2 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.6.2 South America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.7.2 Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET PRODUCTION BY REGION
9.1 Global Production of Non-24-hour Sleep-wake Disorder Treatment by Region(2020-2025)
9.2 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2020-2025)
9.3 Global Non-24-hour Sleep-wake Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Non-24-hour Sleep-wake Disorder Treatment Production
9.4.1 North America Non-24-hour Sleep-wake Disorder Treatment Production Growth Rate (2020-2025)
9.4.2 North America Non-24-hour Sleep-wake Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Non-24-hour Sleep-wake Disorder Treatment Production
9.5.1 Europe Non-24-hour Sleep-wake Disorder Treatment Production Growth Rate (2020-2025)
9.5.2 Europe Non-24-hour Sleep-wake Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Non-24-hour Sleep-wake Disorder Treatment Production (2020-2025)
9.6.1 Japan Non-24-hour Sleep-wake Disorder Treatment Production Growth Rate (2020-2025)
9.6.2 Japan Non-24-hour Sleep-wake Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Non-24-hour Sleep-wake Disorder Treatment Production (2020-2025)
9.7.1 China Non-24-hour Sleep-wake Disorder Treatment Production Growth Rate (2020-2025)
9.7.2 China Non-24-hour Sleep-wake Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Teva
10.1.1 Teva Basic Information
10.1.2 Teva Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.1.4 Teva Business Overview
10.1.5 Teva SWOT Analysis
10.1.6 Teva Recent Developments
10.2 Mylan
10.2.1 Mylan Basic Information
10.2.2 Mylan Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.2.4 Mylan Business Overview
10.2.5 Mylan SWOT Analysis
10.2.6 Mylan Recent Developments
10.3 Nature?s Bounty
10.3.1 Nature?s Bounty Basic Information
10.3.2 Nature?s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.3.3 Nature?s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.3.4 Nature?s Bounty Business Overview
10.3.5 Nature?s Bounty SWOT Analysis
10.3.6 Nature?s Bounty Recent Developments
10.4 Otsuka Pharma (Pharmavite)
10.4.1 Otsuka Pharma (Pharmavite) Basic Information
10.4.2 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.4.4 Otsuka Pharma (Pharmavite) Business Overview
10.4.5 Otsuka Pharma (Pharmavite) Recent Developments
10.5 Boiron
10.5.1 Boiron Basic Information
10.5.2 Boiron Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.5.4 Boiron Business Overview
10.5.5 Boiron Recent Developments
10.6 Miers Laboratories
10.6.1 Miers Laboratories Basic Information
10.6.2 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.6.4 Miers Laboratories Business Overview
10.6.5 Miers Laboratories Recent Developments
10.7 Genexa
10.7.1 Genexa Basic Information
10.7.2 Genexa Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.7.4 Genexa Business Overview
10.7.5 Genexa Recent Developments
10.8 Homeocan
10.8.1 Homeocan Basic Information
10.8.2 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.8.4 Homeocan Business Overview
10.8.5 Homeocan Recent Developments
10.9 Clinigen Group
10.9.1 Clinigen Group Basic Information
10.9.2 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.9.4 Clinigen Group Business Overview
10.9.5 Clinigen Group Recent Developments
10.10 Vanda Pharma
10.10.1 Vanda Pharma Basic Information
10.10.2 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Overview
10.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
10.10.4 Vanda Pharma Business Overview
10.10.5 Vanda Pharma Recent Developments
11 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET FORECAST BY REGION
11.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast
11.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country
11.2.3 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region
11.2.4 South America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Non-24-hour Sleep-wake Disorder Treatment by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Non-24-hour Sleep-wake Disorder Treatment by Type (2026-2035)
12.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Non-24-hour Sleep-wake Disorder Treatment by Type (2026-2035)
12.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Application (2026-2035)
12.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) Forecast by Application
12.2.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (M USD)
Table 4. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application
Table 5. Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison by Region (M USD)
Table 6. Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Non-24-hour Sleep-wake Disorder Treatment Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-24-hour Sleep-wake Disorder Treatment as of 2025)
Table 11. Global Market Non-24-hour Sleep-wake Disorder Treatment Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Non-24-hour Sleep-wake Disorder Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-24-hour Sleep-wake Disorder Treatment Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Type (K MT)
Table 27. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (M USD)
Table 28. Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) by Type (2020-2025)
Table 29. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Type (2020-2025)
Table 30. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) by Type (2020-2025)
Table 31. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Type (2020-2025)
Table 32. Global Non-24-hour Sleep-wake Disorder Treatment Price (USD/KG) by Type (2020-2025)
Table 33. Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) by Application
Table 34. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application
Table 35. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Application (2020-2025) & (K MT)
Table 36. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application (2020-2025)
Table 37. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2020-2025) & (M USD)
Table 38. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application (2020-2025)
Table 39. Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2020-2025)
Table 40. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2020-2025) & (K MT)
Table 41. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region (2020-2025)
Table 42. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025) & (M USD)
Table 43. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025)
Table 44. North America Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2020-2025) & (K MT)
Table 45. North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2020-2025) & (K MT)
Table 47. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025) & (M USD)
Table 50. South America Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2020-2025) & (K MT)
Table 51. South America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025) & (M USD)
Table 54. Global Non-24-hour Sleep-wake Disorder Treatment Production (K MT) by Region(2020-2025)
Table 55. Global Non-24-hour Sleep-wake Disorder Treatment Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2020-2025)
Table 57. Global Non-24-hour Sleep-wake Disorder Treatment Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Non-24-hour Sleep-wake Disorder Treatment Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Non-24-hour Sleep-wake Disorder Treatment Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Non-24-hour Sleep-wake Disorder Treatment Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Non-24-hour Sleep-wake Disorder Treatment Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Teva Basic Information
Table 63. Teva Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 64. Teva Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Teva Business Overview
Table 66. Teva SWOT Analysis
Table 67. Teva Recent Developments
Table 68. Mylan Basic Information
Table 69. Mylan Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 70. Mylan Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Mylan Business Overview
Table 72. Mylan SWOT Analysis
Table 73. Mylan Recent Developments
Table 74. Nature?s Bounty Basic Information
Table 75. Nature?s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 76. Nature?s Bounty Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Nature?s Bounty Business Overview
Table 78. Nature?s Bounty SWOT Analysis
Table 79. Nature?s Bounty Recent Developments
Table 80. Otsuka Pharma (Pharmavite) Basic Information
Table 81. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 82. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Otsuka Pharma (Pharmavite) Business Overview
Table 84. Otsuka Pharma (Pharmavite) Recent Developments
Table 85. Boiron Basic Information
Table 86. Boiron Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 87. Boiron Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Boiron Business Overview
Table 89. Boiron Recent Developments
Table 90. Miers Laboratories Basic Information
Table 91. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 92. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Miers Laboratories Business Overview
Table 94. Miers Laboratories Recent Developments
Table 95. Genexa Basic Information
Table 96. Genexa Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 97. Genexa Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Genexa Business Overview
Table 99. Genexa Recent Developments
Table 100. Homeocan Basic Information
Table 101. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 102. Homeocan Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Homeocan Business Overview
Table 104. Homeocan Recent Developments
Table 105. Clinigen Group Basic Information
Table 106. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 107. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Clinigen Group Business Overview
Table 109. Clinigen Group Recent Developments
Table 110. Vanda Pharma Basic Information
Table 111. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 112. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Vanda Pharma Business Overview
Table 114. Vanda Pharma Recent Developments
Table 115. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Non-24-hour Sleep-wake Disorder Treatment Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (M USD)
Table 4. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application
Table 5. Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison by Region (M USD)
Table 6. Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Non-24-hour Sleep-wake Disorder Treatment Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-24-hour Sleep-wake Disorder Treatment as of 2025)
Table 11. Global Market Non-24-hour Sleep-wake Disorder Treatment Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Non-24-hour Sleep-wake Disorder Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-24-hour Sleep-wake Disorder Treatment Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Type (K MT)
Table 27. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (M USD)
Table 28. Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) by Type (2020-2025)
Table 29. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Type (2020-2025)
Table 30. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) by Type (2020-2025)
Table 31. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Type (2020-2025)
Table 32. Global Non-24-hour Sleep-wake Disorder Treatment Price (USD/KG) by Type (2020-2025)
Table 33. Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) by Application
Table 34. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application
Table 35. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Application (2020-2025) & (K MT)
Table 36. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application (2020-2025)
Table 37. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2020-2025) & (M USD)
Table 38. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application (2020-2025)
Table 39. Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2020-2025)
Table 40. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2020-2025) & (K MT)
Table 41. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region (2020-2025)
Table 42. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025) & (M USD)
Table 43. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025)
Table 44. North America Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2020-2025) & (K MT)
Table 45. North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2020-2025) & (K MT)
Table 47. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025) & (M USD)
Table 50. South America Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2020-2025) & (K MT)
Table 51. South America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025) & (M USD)
Table 54. Global Non-24-hour Sleep-wake Disorder Treatment Production (K MT) by Region(2020-2025)
Table 55. Global Non-24-hour Sleep-wake Disorder Treatment Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Region (2020-2025)
Table 57. Global Non-24-hour Sleep-wake Disorder Treatment Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Non-24-hour Sleep-wake Disorder Treatment Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Non-24-hour Sleep-wake Disorder Treatment Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Non-24-hour Sleep-wake Disorder Treatment Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Non-24-hour Sleep-wake Disorder Treatment Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Teva Basic Information
Table 63. Teva Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 64. Teva Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Teva Business Overview
Table 66. Teva SWOT Analysis
Table 67. Teva Recent Developments
Table 68. Mylan Basic Information
Table 69. Mylan Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 70. Mylan Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Mylan Business Overview
Table 72. Mylan SWOT Analysis
Table 73. Mylan Recent Developments
Table 74. Nature?s Bounty Basic Information
Table 75. Nature?s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 76. Nature?s Bounty Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Nature?s Bounty Business Overview
Table 78. Nature?s Bounty SWOT Analysis
Table 79. Nature?s Bounty Recent Developments
Table 80. Otsuka Pharma (Pharmavite) Basic Information
Table 81. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 82. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Otsuka Pharma (Pharmavite) Business Overview
Table 84. Otsuka Pharma (Pharmavite) Recent Developments
Table 85. Boiron Basic Information
Table 86. Boiron Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 87. Boiron Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Boiron Business Overview
Table 89. Boiron Recent Developments
Table 90. Miers Laboratories Basic Information
Table 91. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 92. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Miers Laboratories Business Overview
Table 94. Miers Laboratories Recent Developments
Table 95. Genexa Basic Information
Table 96. Genexa Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 97. Genexa Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Genexa Business Overview
Table 99. Genexa Recent Developments
Table 100. Homeocan Basic Information
Table 101. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 102. Homeocan Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Homeocan Business Overview
Table 104. Homeocan Recent Developments
Table 105. Clinigen Group Basic Information
Table 106. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 107. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Clinigen Group Business Overview
Table 109. Clinigen Group Recent Developments
Table 110. Vanda Pharma Basic Information
Table 111. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 112. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Vanda Pharma Business Overview
Table 114. Vanda Pharma Recent Developments
Table 115. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Non-24-hour Sleep-wake Disorder Treatment Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Non-24-hour Sleep-wake Disorder Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD), 2025-2035
Figure 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) (2020-2035)
Figure 6. Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Non-24-hour Sleep-wake Disorder Treatment Product Life Cycle
Figure 13. Non-24-hour Sleep-wake Disorder Treatment Sales Share by Manufacturers in 2025
Figure 14. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Manufacturers in 2025
Figure 15. Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Non-24-hour Sleep-wake Disorder Treatment Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Non-24-hour Sleep-wake Disorder Treatment Revenue in 2025
Figure 18. Industry Chain Map of Non-24-hour Sleep-wake Disorder Treatment
Figure 19. Global Non-24-hour Sleep-wake Disorder Treatment Market PEST Analysis
Figure 20. Global Non-24-hour Sleep-wake Disorder Treatment Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Type
Figure 27. Sales Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type (2020-2025)
Figure 28. Sales Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type in 2025
Figure 29. Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type (2020-2025)
Figure 30. Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application
Figure 33. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application (2020-2025)
Figure 34. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application in 2025
Figure 35. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application (2020-2025)
Figure 36. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application in 2025
Figure 37. Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2020-2025)
Figure 38. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region (2020-2025)
Figure 39. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025)
Figure 40. North America Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2024
Figure 43. North America Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country in 2024
Figure 45. U.S. Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Non-24-hour Sleep-wake Disorder Treatment Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Non-24-hour Sleep-wake Disorder Treatment Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2024
Figure 53. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country in 2024
Figure 55. Germany Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region in 2024
Figure 67. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region in 2024
Figure 68. China Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (K MT)
Figure 79. South America Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2024
Figure 80. South America Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (M USD)
Figure 81. South America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country in 2024
Figure 82. Brazil Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Region in 2024
Figure 92. Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Non-24-hour Sleep-wake Disorder Treatment Production Market Share by Region (2020-2025)
Figure 103. North America Non-24-hour Sleep-wake Disorder Treatment Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Non-24-hour Sleep-wake Disorder Treatment Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Non-24-hour Sleep-wake Disorder Treatment Production (K MT) Growth Rate (2020-2025)
Figure 106. China Non-24-hour Sleep-wake Disorder Treatment Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Type (2026-2035)
Figure 111. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Application (2026-2035)
Figure 112. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Non-24-hour Sleep-wake Disorder Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD), 2025-2035
Figure 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) (2020-2035)
Figure 6. Global Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Non-24-hour Sleep-wake Disorder Treatment Product Life Cycle
Figure 13. Non-24-hour Sleep-wake Disorder Treatment Sales Share by Manufacturers in 2025
Figure 14. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Manufacturers in 2025
Figure 15. Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Non-24-hour Sleep-wake Disorder Treatment Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Non-24-hour Sleep-wake Disorder Treatment Revenue in 2025
Figure 18. Industry Chain Map of Non-24-hour Sleep-wake Disorder Treatment
Figure 19. Global Non-24-hour Sleep-wake Disorder Treatment Market PEST Analysis
Figure 20. Global Non-24-hour Sleep-wake Disorder Treatment Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Type
Figure 27. Sales Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type (2020-2025)
Figure 28. Sales Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type in 2025
Figure 29. Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type (2020-2025)
Figure 30. Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application
Figure 33. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application (2020-2025)
Figure 34. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application in 2025
Figure 35. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application (2020-2025)
Figure 36. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application in 2025
Figure 37. Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2020-2025)
Figure 38. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region (2020-2025)
Figure 39. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025)
Figure 40. North America Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2024
Figure 43. North America Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country in 2024
Figure 45. U.S. Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Non-24-hour Sleep-wake Disorder Treatment Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Non-24-hour Sleep-wake Disorder Treatment Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Non-24-hour Sleep-wake Disorder Treatment Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2024
Figure 53. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country in 2024
Figure 55. Germany Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region in 2024
Figure 67. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region in 2024
Figure 68. China Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (K MT)
Figure 79. South America Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2024
Figure 80. South America Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (M USD)
Figure 81. South America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country in 2024
Figure 82. Brazil Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Region in 2024
Figure 92. Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Non-24-hour Sleep-wake Disorder Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Non-24-hour Sleep-wake Disorder Treatment Production Market Share by Region (2020-2025)
Figure 103. North America Non-24-hour Sleep-wake Disorder Treatment Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Non-24-hour Sleep-wake Disorder Treatment Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Non-24-hour Sleep-wake Disorder Treatment Production (K MT) Growth Rate (2020-2025)
Figure 106. China Non-24-hour Sleep-wake Disorder Treatment Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Type (2026-2035)
Figure 111. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Application (2026-2035)
Figure 112. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Application (2026-2035)
